DE69632407D1 - Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung - Google Patents

Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung

Info

Publication number
DE69632407D1
DE69632407D1 DE69632407T DE69632407T DE69632407D1 DE 69632407 D1 DE69632407 D1 DE 69632407D1 DE 69632407 T DE69632407 T DE 69632407T DE 69632407 T DE69632407 T DE 69632407T DE 69632407 D1 DE69632407 D1 DE 69632407D1
Authority
DE
Germany
Prior art keywords
selectin
multiplem
prevent
organ
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69632407T
Other languages
English (en)
Other versions
DE69632407T2 (de
Inventor
Anton Haselbeck
Guenther Schumacher
Sung Co
Ulrich Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PDL Biopharma Inc
Original Assignee
Protein Design Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Design Labs Inc filed Critical Protein Design Labs Inc
Publication of DE69632407D1 publication Critical patent/DE69632407D1/de
Application granted granted Critical
Publication of DE69632407T2 publication Critical patent/DE69632407T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69632407T 1995-08-17 1996-08-14 Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung Expired - Fee Related DE69632407T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP95112895 1995-08-17
EP95112895 1995-08-17
EP95114696 1995-09-19
EP95114696 1995-09-19
US57895395A 1995-12-27 1995-12-27
US578953 1995-12-27
PCT/US1996/013152 WO1997006822A1 (en) 1995-08-17 1996-08-14 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage

Publications (2)

Publication Number Publication Date
DE69632407D1 true DE69632407D1 (de) 2004-06-09
DE69632407T2 DE69632407T2 (de) 2005-06-02

Family

ID=27236574

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632407T Expired - Fee Related DE69632407T2 (de) 1995-08-17 1996-08-14 Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung

Country Status (11)

Country Link
EP (1) EP0868197B1 (de)
JP (1) JP3604699B2 (de)
AT (1) ATE265861T1 (de)
AU (1) AU6773596A (de)
CA (1) CA2229140A1 (de)
CZ (1) CZ45498A3 (de)
DE (1) DE69632407T2 (de)
HU (1) HUP9901673A3 (de)
PL (1) PL187090B1 (de)
WO (1) WO1997006822A1 (de)
ZA (1) ZA966954B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172213B1 (en) 1997-07-02 2001-01-09 Genentech, Inc. Anti-IgE antibodies and method of improving polypeptides
US5994511A (en) * 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
GB9919713D0 (en) * 1999-08-19 1999-10-20 Queen Mary & Westfield College New medical use of high density lipoprotein
ME00804B (me) 2002-03-13 2012-03-20 Biogen Idec Inc Anti-alpha v beta 6 antitela
CN104072614B (zh) 2005-07-08 2017-04-26 生物基因Ma公司 抗-αvβ6 抗体及其用途
EP2046374A4 (de) 2006-07-10 2010-05-05 Biogen Idec Inc Zusammensetzungen und verfahren zur wachstumshemmung von smad4-defizienten tumoren
WO2014144466A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof
US10035860B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
EP3883636A1 (de) 2018-11-19 2021-09-29 Progenity, Inc. Einnehmbare vorrichtung zur abgabe eines therapeutikums an den magen-darm-trakt
EP4309722A2 (de) 2019-12-13 2024-01-24 Biora Therapeutics, Inc. Einnehmbare vorrichtung zur abgabe eines therapeutischen mittels an den magen-darm-trakt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232780T2 (de) * 1991-06-25 2003-01-30 Dana Farber Cancer Inst Inc Monoklonaler antikörper gegen lymphozytenassoziiertes zelloberflächenprotein
WO1993002698A1 (en) * 1991-07-29 1993-02-18 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies to leukocyte adhesion molecule-1
AU689090B2 (en) * 1992-12-01 1998-03-26 Protein Design Labs, Inc. Humanized antibodies reactive with L-selectin
WO1995015181A1 (en) * 1993-11-30 1995-06-08 Protein Design Labs, Inc. Reperfusion therapy using antibodies to l-selectin

Also Published As

Publication number Publication date
WO1997006822A1 (en) 1997-02-27
JPH10510553A (ja) 1998-10-13
EP0868197B1 (de) 2004-05-06
CA2229140A1 (en) 1997-02-27
EP0868197A4 (de) 1998-11-18
ZA966954B (en) 1998-02-16
HUP9901673A2 (hu) 1999-08-30
JP3604699B2 (ja) 2004-12-22
ATE265861T1 (de) 2004-05-15
DE69632407T2 (de) 2005-06-02
PL187090B1 (pl) 2004-05-31
AU6773596A (en) 1997-03-12
EP0868197A1 (de) 1998-10-07
PL325012A1 (en) 1998-07-06
HUP9901673A3 (en) 2001-06-28
CZ45498A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
NO982310L (no) Protegriner
WO2001077951A8 (en) System and methods for group retirement plan administration
NO982055L (no) 2-alkylpyrrolidiner
RU94028653A (ru) Фармацевтический препарат
AU2266297A (en) Recovery of taxanes from conifers
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO975557D0 (no) Immortalisering og dismortalisering av celler
ATE234091T1 (de) Thrombin inhibitoren
FI971536A0 (fi) Keratinosyytti-kasvutekijän analogeja
DE69632407D1 (de) Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung
NO983530D0 (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
DE69625230D1 (de) Thrombininhibitoren
DE69616074D1 (de) Ara-c derivate
FI944563A (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
BR9609114A (pt) Composição inseticida de terra diatomácea
BR9606955A (pt) Heterocicloalquenos substituísos
DE29517506U1 (de) Sonnenschutzpflaster selbstklebend
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
DE69623464T2 (de) Modifizierte kojibioside analoge
DE69717147T2 (de) Thrombin inhibitoren
ATE240114T1 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
ITMI921597A0 (it) Procedimento di consolidamento di costruzioni, particolarmente torri e campanili
RU95117476A (ru) Природный дубитель кожи

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee